1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cell-free (cf)DNA analysis identifies PIK3CA/AKT1 mutations associated with greater PFS improvement from the addition of ipatasertib (IPAT) to paclitaxel (P) in triple-negative breast cancer (TNBC)
    Meeting Abstract

    Wongchenko, M.; Dent, R.; Kim, S. B.; Saura, C.; Oliveira, M.; Baselga, J.; Kapp, A. V.; Chan, W. Y.; Singel, S. M.; Maslyar, D. J.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A modular and generalizable route to potent, selective and pharmacologically compliant inhibitors of rhomboid proteases
    Meeting Abstract

    Ticha, A.; Stanchev, S.; Vinothkumar, K.; Mikles, D.; Pachl, P.; Svehlova, K.; Nguyen, M.; Verhelst, S.; Johnson, D.; Bachovchin, D.; more...
    FEBS Journal (2017)

    Fulltext@MSK | Save
  • Anticancer efficacy of the hypoxia-activated pro-drug evofosfamide in prcelinIcal osteosarcoma murine models
    Meeting Abstract

    Liapis, V.; Labrinidis, A.; Zinonos, I.; Hay, S.; Ponomarev, V.; Panagopoulos, V.; DeNichilo, M.; Ingman, W.; Atkins, G. J.; Findlay, D. M.; more...
    International Journal of Molecular Medicine (2017)

    Fulltext@MSK | Save
  • The hypoxia activated pro-drug evofosfamide exhibits tumour suppressive activity and synergy with chemotherapy against primary and metastatic breast cancers
    Meeting Abstract

    Liapis, V.; Zinonos, I.; Labrinidis, A.; Hay, S.; Ponomarev, V.; Panagopoulos, V.; Zysk, A.; DeNichilo, M.; Ingman, W.; Atkins, G. J.; more...
    International Journal of Molecular Medicine (2017)

    Fulltext@MSK | Save
  • Potential impact of avelumab + axitinib (A + Ax) on tumor size (TS) compared with historical data of sunitinib (S) as evaluated by a modeling and simulation (MS) approach
    Meeting Abstract

    Zheng, J.; Chang, A.; Larkin, J.; Motzer, R. J.; Amantea, M.; Bello, C.; Pavlov, D.; Geraldes, M.; Martignoni, M.; Di Pietro, A.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Chronic inflammation regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes
    Meeting Abstract

    Loupasakis, K.; Kuo, D.; Sohn, C.; Syracuse, B.; Giannopoulou, E. G.; Park, S. H.; Rätsch, G.; Ivashkiv, L. B.; Kalliolias, G. D.
    Annals of the Rheumatic Diseases (2017)

    Fulltext@MSK | Save
  • Efficacy and immune activation with PEGylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC: Update
    Meeting Abstract

    Wong, D. J.; Schneider, J. G.; Aljumaily, R.; Korn, M. W.; Autio, K.; Infante, J. R.; Patel, M. R.; Papadopoulos, K.; Naing, A.; Gabrail, N.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A survey of patient acceptance of skin toxicities from cetuximab-based therapy
    Meeting Abstract

    Tischer, B.; Bilang, M.; Ronga, P.; Lacouture, M. E.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Literature review of TPOR agonists for CIT
    Meeting Abstract

    Soff, G. A.; Ray-Coquard, I.; Marfil-Rivera, L. J.; Fryzek, J.; Mullins, M.; Bylsma, L. C.; Park, J. K.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Summary of head-to-head comparisons of patient (pt) risk classifications by the 21-gene recurrence score (RS) assay and other genomic assays for early breast cancer (EBC)
    Meeting Abstract

    Varga, Z.; Sinn, P.; McCullough, D.; Lau, A.; Stöppler, M. C.; Baehner, F. L.; Chao, C.; Seidman, A.
    Annals of Oncology (2017)

    Fulltext@MSK | Save